Gitterman Wealth Management, LLC Bristol Myers Squibb CO Transaction History
Gitterman Wealth Management, LLC
- $369 Million
- Q2 2025
A detailed history of Gitterman Wealth Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Gitterman Wealth Management, LLC holds 5,212 shares of BMY stock, worth $242,618. This represents 0.07% of its overall portfolio holdings.
Number of Shares
5,212
Previous 5,166
0.89%
Holding current value
$242,618
Previous $315,000
23.49%
% of portfolio
0.07%
Previous 0.1%
Shares
5 transactions
Others Institutions Holding BMY
# of Institutions
2,665Shares Held
1.6BCall Options Held
26.2MPut Options Held
23.5M-
Vanguard Group Inc Valley Forge, PA195MShares$9.07 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.39 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.03 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.41 Billion0.24% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.3 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...